测试版
试验雷达 AI
一个试验符合筛选条件
卡片视图

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy. 66 随机化

招募中
临床试验详情主要以英语提供。然而,试验雷达 AI可以提供帮助!只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT06640894 (Power2Walk)是一项针对痉挛性脑瘫干预性研究试验,目前试验状态为招募中。试验始于2024年7月19日,计划招募66名患者。该研究由Amsterdam UMC, location VUmc主导,预计于2027年8月31日完成。试验数据来源于ClinicalTrials.gov,最后更新时间为2025年12月29日
简要概括
Rationale: Children with cerebral palsy (CP) experience limitations in walking ability due to functional motor impairments caused by neurodevelopmental damage during fetal or early child development. Due to these motor impairments, children with CP struggle to keep up with typically developing peers when participating in physical and/or social activities. Consequently, the development of these children may be hampere...显示更多
详细描述
Children with cerebral palsy (CP) experience limitations in walking ability due to functional motor impairments caused by neurodevelopmental damage during fetal or early child development that may result in spasticity, dyskinesia, or ataxia. Due to these motor impairments, children with CP struggle to keep up with typically developing peers when participating in physical and/or social activities. Yet, participation i...显示更多
官方标题

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy - A Randomized Controlled Trial

疾病
痉挛性脑瘫
其他研究标识符
  • Power2Walk
  • NL85905.018.23
  • 2024.0022 (其他标识符) (METC Amsterdam UMC)
NCT编号
实际开始日期
2024-07-19
最近更新发布
2025-12-29
预计完成日期
2027-08-31
计划入组人数
66
研究类型
干预性研究
试验分期 (阶段)
不适用
试验状态
招募中
关键词
Cerebral palsy
主要目的
治疗方法
分配方式
随机
干预模型
平行
盲法
单盲
试验组/干预措施
参与者组/试验组干预措施/治疗方法
实验性Intervention (MegaPower training)
MegaPower training is a twelve-week long functional power training program in which children will perform functional power training three times a week together with a personal trainer. During the intervention, training volume will be influenced by training weight, velocity of movement, and amount of repetitions. The training program has the following characteristics: 1. (Weighted) functional exercises like walking, ...显示更多
MegaPower training
See arm/group descriptions
阳性对照Control (Usual Care)
The control group will receive their usual care for twelve weeks (non-intervention group). This usual care consists of physiotherapy appointments, for example.
常规护理
See arm/group descriptions
主要终点
结果指标度量标准描述时间框架
Goal Attainment (Goal Attainment Scaling)
Goal Attainment Scaling (GAS) is a method used to measure the achievement of individual goals in a structured and quantitative manner. It is commonly used in clinical and educational settings to evaluate progress and outcomes. Each goal is scaled on a six-point scale, ranging from -3 to +2: Goal Attainment Scaling endpoints will be formulated according to SMART-principles to standardize results.
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
次要终点
结果指标度量标准描述时间框架
Mobility Questionnaire 28 (MobQues28)
The MobQues28 is a parent-reported mobility questionnaire used in cerebral palsy research that assesses gait-related function across different domains of the International Classification of Functioning, Disability and Health (ICF) developed for ambulant children with CP.
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Gait Outcomes Assessment List (GOAL)
The GOAL is a parent-reported mobility questionnaire that assesses gait-related function across different domains of the ICF and is developed for ambulant children with CP. The GOAL is a more comprehensive and better standardized version of the MobQues28. However, since our study population is based off expected differences in the MobQues28 (since data for the GOAL on this subject does not exist yet), both questionnaires are included.
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Harter's Self-Perception Profile for Children
Harter's Self-Perception Profile for Children (HSPPC) is a psychological assessment tool designed to measure self-concept in children. Children will be assessed on the domains of social competence, athletic competence, and global self-worth.
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Physical activity (accelerometer)
Physical activity will be measured over a 7-day period using a wearable accelerometer that participants will have to carry for seven days. The accelerometer picks up accelerations of the body and can accurately estimate physical (in)activity accordingly. The accelerometer does not have an interface and does not save any personal data.
Baseline (t = 0 weeks); t = 12 weeks
Sleep (accelerometer)
Sleep will be measured over a 7-day period using a wearable accelerometer that participants will have to carry for seven days. The accelerometer picks up accelerations of the body and can estimate sleep duration and quality. The accelerometer does not have an interface and does not save any personal data.
Baseline (t = 0 weeks); t = 12 weeks
Body composition (bioelectrical impedance analysis)
Body composition; measured using bioelectrical impedance analysis (BIA). BIA is a method to assess body composition based on the resistance of different tissue types against an unnoticeable electric pulse through the body, since fat mass and fat free mass have a different conductivity.
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Walking speed (1-minute walk test)
The 1-minute walk test is a physical test that measures walking speed. The child is asked to walk as quickly as possible around a measured track for a period of one minute. The distance walked within 1 minute is measured and recorded.
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Aerobic endurance (shuttle run test)
The shuttle run test is a physical test that measures aerobic endurance. Children walk or run at a set incremental speed between two markers that are placed ten meters apart. These walks/runs are coordinated by a recorded CD that plays a sound at pre-determined intervals. Children have to keep up with the speed of these intervals and are measured by the level they reached. Different validated tests will be used for children of different GMFCS levels.
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Anaerobic capacity (muscle power sprint test).
The Muscle Power Sprint Test is a physical test that measures anaerobic capacity. Children have to perform a fifteen meter sprint as fast as possible, repeated six times with ten seconds of rest in between. Their score will be presented in mean and peak power (force \* speed).
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Dietary intake (3-day food record)
Dietary intake at baseline; measured using a 3-day food record in which parents have to track the nutritional intake of their child during two week days and one weekend day.
Baseline (t = 0 weeks).
Process evaluation
A process evaluation will be employed to monitor and document program implementation. With this information, the goal is to evaluate to what extend the MegaPower training was implemented as intended in the participating study centers. This allows us to understand the relationship between specific program elements and program outcomes. The framework by Saunders et al., describing five components of process evaluation will be used. The methods proposed contains questionnaires, report and registration forms, interviews, and focus groups. As a part of this process evaluation, parents will also be asked to fill out a questionnaire about whether their child is happy with the care they received.
Through study completion. An average of 2 years.
Age
Age (years and months) at start of study.
Baseline (t = 0 weeks)
Height (cm)
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Weight (kg)
Baseline (t = 0 weeks); t = 12 weeks, t = 24 weeks, t = 36 weeks.
Gender (male/female/other)
Baseline (t = 0 weeks)
GMFCS level (I, II, or III)
The mobility and gross motor skills of people with cerebral palsy are categorized into five different levels using a tool called the Gross Motor Function Classification System (GMFCS).
Baseline (t = 0 weeks)
Type of cerebral palsy
Spastic/dyskinetic/ataxic/unilateral/bilateral/hemiplegia/diplegia/quadriplegia/other.
Baseline (t = 0 weeks)
Type of education (regular/special)
Baseline (t = 0 weeks)
Education level of parent(s)
Baseline (t = 0 weeks)
Use of ankle-foot orthoses (yes/no)
Baseline (t = 0 weeks)
Participation in sports
Do the child and the family of the child participate in any sports? And if so, how many times a week?
Baseline (t = 0 weeks)
参与助手
资格标准

适龄参与研究
儿童
最低年龄要求
4 Years
适龄性别
全部
  • Children with cerebral palsy or a related non-progressive disorder between the ages of 4 to 12.
  • Gross Motor Function Classification System (GMFCS) level I - III.
  • Parents and/or children have a treatment question related to participation of the child.

  • Participants that suffer from a progressive neurological disorder.
  • Treatment with botulinum toxin and/or serial casting in lower extremities planned during the study period.
  • Treatment with botulinum toxin in the twelve weeks prior to participation in the study.
  • Treatment with serial casting in the three weeks prior to participation in the study.
  • Children that underwent a selective dorsal rhizotomy twelve months prior to participation in the study.
  • Children that underwent orthopedic surgery on their lower extremities in the 12 months before participation in the study.
  • Children that have received MegaPower training in the last 4 months before participation in the study.
  • Children for whom walking is not their preferred method of locomotion (yet).
Amsterdam UMC, location VUmc logoAmsterdam UMC, location VUmc
研究责任方
Rijk Dersjant, 主要研究者, Coordinating investigator, VU University of Amsterdam
研究中心联系人
联系人: Rijk Dersjant, drs., +31 20 4440761, [email protected]
联系人: Marjolein M. Van der Krogt, dr., +31 20 4440789, [email protected]
10 位于 1 个国家/地区的研究中心

Drenthe

Treant Zorggroep, Emmen, Drenthe, Netherlands
Marije Koning, 联系人, +31 88 129 29 29, [email protected]
招募中

Flevoland

Merem, Almere Stad, Flevoland, Netherlands
Elise Hooft, drs., 联系人, [email protected]
Elise Hooft, drs., 主要研究者
招募中

Limburg

Adelante zorggroep, Valkenburg, Limburg, Netherlands
Eugene A. Rameckers, dr., 联系人, [email protected]
Eugene A. Rameckers, dr., 主要研究者
招募中

North Brabant

Revant, Breda, North Brabant, Netherlands
Jens van Helleman, 联系人, +31 88 735 8000, [email protected]
Jens van Helleman, 主要研究者
尚未招募

North Holland

Reade, Amsterdam, North Holland, Netherlands
Liesbeth F. Van Vulpen, dr., 联系人, [email protected]
Liesbeth F. Van Vulpen, dr., 主要研究者
招募中
Heliomare, Heemskerk, North Holland, Netherlands
Jette E. Van Egmond, drs., 联系人, [email protected]
Jette E. Van Egmond, drs., 主要研究者
招募中
Merem, Hilversum, North Holland, Netherlands
Elise Hooft, drs., 联系人, [email protected]
Jeffrey van Limpt, 主要研究者
招募中

Overijssel

Roessingh, Enschede, Overijssel, Netherlands
Marc Nederhand, dr., 联系人, +31 53 487 5875, [email protected]
Jolienke Colenbrander, 主要研究者
招募中

Provincie Friesland

Revalidatie Friesland, Beetsterzwaag, Provincie Friesland, 9244CL, Netherlands
Heleen Reinders-Messelink, dr., 联系人, +31 88 5801580, [email protected]
Fokke Fennema, 主要研究者
招募中

Zeeland

Revant, Goes, Zeeland, Netherlands
Jens van Helleman, 联系人, +31 88 735 8000, [email protected]
Jens van Helleman, 主要研究者
尚未招募